HuGE Literature Finder
Records 1-8
|
Cytokine rs361525, rs1800750, rs1800629, rs1800896, rs1800872, rs1800795, rs1800470, and rs2430561 SNPs in relation with prognostic factors in acute myeloid leukemia.
Cancer medicine 2019 Aug . Banescu Claudia, Tripon Florin, Trifa Adrian P, Crauciuc Andrei G, Moldovan Valeriu G, Boglis Alina, Benedek Istvan, Dima Delia, Cândea Marcela, Duicu Carmen, Iancu Mihae |
|
EGFR mono-antibody salvage therapy for locally advanced and distant metastatic penile cancer: Clinical outcomes and genetic analysis.
Urologic oncology 2019 01 37 (1): 71-77. Huang Kang-Bo, Liu Ran-Yi, Peng Qi-Hua, Li Zai-Shang, Jiang Li-Juan, Guo Sheng-Jie, Zhou Qiang-Hua, Liu Ting-Yu, Deng Chuang-Zhong, Yao Kai, Qin Zi-Ke, Liu Zhuo-Wei, Li Yong-Hong, Han Hui, Zhou Fang-Ji |
|
Presence of copy number aberration and clinical prognostic factors in patients with acute myeloid leukemia: an analysis of effect modification.
Polish archives of internal medicine 2019 12 . Banescu Claudia, Tripon Florin, Trifa Adrian P, Crauciuc Andrei G, Bogli? Alina, Lazar Erzsebet, Dima Delia, Macarie Ioan, Duicu Carmen, Iancu Mihae |
|
The Role of FLT3-ITD Mutation on de Novo MDS in Chinese Population.
Clinical lymphoma, myeloma & leukemia 2018 Nov . Xu Fei, Han Rong, Zhang Jian, Li Zheng, Wang Jun, Chu Xiao-Ling, Yu Jing-Qiu, Wang Chao, Tao Tao, Shen Hong-Jie, Chen Su-Ning, Wu De-Pei, Liu Song-Bai, Qiu Qiao-Cheng, Xue Sheng- |
|
Phase I/II trial of the combination of midostaurin (PKC412) and 5-azacytidine for patients with acute myeloid leukemia and myelodysplastic syndrome.
American journal of hematology 2015 Apr 90 (4): 276-81. Strati Paolo, Kantarjian Hagop, Ravandi Farhad, Nazha Aziz, Borthakur Gautam, Daver Naval, Kadia Tapan, Estrov Zeev, Garcia-Manero Guillermo, Konopleva Marina, Rajkhowa Trivikram, Durand Menda, Andreeff Michael, Levis Mark, Cortes Jor |
|
TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution.
Blood cancer journal 2015 5 e331. Hou H-A, Chou W-C, Kuo Y-Y, Liu C-Y, Lin L-I, Tseng M-H, Chiang Y-C, Liu M-C, Liu C-W, Tang J-L, Yao M, Li C-C, Huang S-Y, Ko B-S, Hsu S-C, Chen C-Y, Lin C-T, Wu S-J, Tsay W, Chen Y-C, Tien H |
|
Screening for hotspot mutations in PI3K, JAK2, FLT3 and NPM1 in patients with myelodysplastic syndromes.
Clinics (São Paulo, Brazil) 2011 66 (5): 793-9. Machado-Neto João Agostinho, Traina Fabiola, Lazarini Mariana, Campos Paula de Melo, Pagnano Katia Borgia Barbosa, Lorand-Metze Irene, Costa Fernando Ferreira, Saad Sara T Olal |
|
High-frequency type I/II mutational shifts between diagnosis and relapse are associated with outcome in pediatric AML: implications for personalized medicine.
Blood 2010 Oct 116 (15): 2752-8. Bachas Costa, Schuurhuis Gerrit Jan, Hollink Iris H I M, Kwidama Zinia J, Goemans Bianca F, Zwaan C Michel, van den Heuvel-Eibrink Marry M, de Bont Eveline S J M, Reinhardt Dirk, Creutzig Ursula, de Haas Valerie, Assaraf Yehuda G, Kaspers Gertjan J L, Cloos Jacqueli |
- Page last reviewed:Oct 1, 2020
- Page last updated:Dec 04, 2020
- Content source: